Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.

Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George DT, Heilig M.

Neuropsychopharmacology. 2011 May;36(6):1178-86. doi: 10.1038/npp.2010.253. Epub 2011 Feb 2.

PMID:
21289601
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.

Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS.

Arch Gen Psychiatry. 1994 Nov;51(11):898-911.

PMID:
7944878
[PubMed - indexed for MEDLINE]
3.

Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.

Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS.

Am J Psychiatry. 1996 Jan;153(1):83-92.

PMID:
8540598
[PubMed - indexed for MEDLINE]
4.

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E.

Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41.

PMID:
12634260
[PubMed - indexed for MEDLINE]
Free Article
5.

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Richardson K, Baillie A, Reid S, Morley K, Teesson M, Sannibale C, Weltman M, Haber P.

Addiction. 2008 Jun;103(6):953-9. doi: 10.1111/j.1360-0443.2008.02215.x.

PMID:
18482418
[PubMed - indexed for MEDLINE]
6.

The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.

Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W.

Eur Neuropsychopharmacol. 2007 Jul;17(8):558-66. Epub 2007 Mar 26.

PMID:
17379484
[PubMed - indexed for MEDLINE]
7.

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

Mason BJ, Goodman AM, Chabac S, Lehert P.

J Psychiatr Res. 2006 Aug;40(5):383-93. Epub 2006 Mar 20.

PMID:
16546214
[PubMed - indexed for MEDLINE]
8.

The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.

Hammarberg A, Jayaram-Lindström N, Beck O, Franck J, Reid MS.

Psychopharmacology (Berl). 2009 Jul;205(1):53-62. doi: 10.1007/s00213-009-1515-6. Epub 2009 Mar 25.

PMID:
19319508
[PubMed - indexed for MEDLINE]
9.

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

Chick J, Howlett H, Morgan MY, Ritson B.

Alcohol Alcohol. 2000 Mar-Apr;35(2):176-87.

PMID:
10787394
[PubMed - indexed for MEDLINE]
Free Article
10.

Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.

Dahl H, Hammarberg A, Franck J, Helander A.

Alcohol Alcohol. 2011 Sep-Oct;46(5):553-7. doi: 10.1093/alcalc/agr055. Epub 2011 May 26.

PMID:
21616946
[PubMed - indexed for MEDLINE]
Free Article
11.

Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.

Kiefer F, Jahn H, Otte C, Demiralay C, Wolf K, Wiedemann K.

J Psychiatr Res. 2005 Sep;39(5):545-51. Epub 2005 Jan 21.

PMID:
15992564
[PubMed - indexed for MEDLINE]
12.

Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP).

Krystal JH, Webb E, Grillon C, Cooney N, Casal L, Morgan CA 3rd, Southwick SM, Davis M, Charney DS.

Psychopharmacology (Berl). 1997 Jun;131(3):207-15.

PMID:
9203230
[PubMed - indexed for MEDLINE]
13.

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, Weltman M, Bell JR, Richardson K, Haber PS.

Addiction. 2006 Oct;101(10):1451-62.

PMID:
16968347
[PubMed - indexed for MEDLINE]
14.
15.

A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.

Weinstein A, Feldtkeller B, Feeney A, Lingford-Hughes A, Nutt D.

Addict Biol. 2003 Jun;8(2):229-32.

PMID:
12850782
[PubMed - indexed for MEDLINE]
16.

Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.

Kampman KM, Pettinati HM, Lynch KG, Xie H, Dackis C, Oslin DW, Sparkman T, Sharkoski T, O'Brien CP.

Addict Behav. 2009 Jun-Jul;34(6-7):581-6. doi: 10.1016/j.addbeh.2009.03.014. Epub 2009 Mar 24.

PMID:
19345510
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.

Verheul R, Lehert P, Geerlings PJ, Koeter MW, van den Brink W.

Psychopharmacology (Berl). 2005 Mar;178(2-3):167-73. Epub 2004 Aug 19.

PMID:
15322728
[PubMed - indexed for MEDLINE]
18.

Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.

Kiefer F, Jahn H, Otte C, Nakovics H, Wiedemann K.

Neurosci Lett. 2006 Aug 14;404(1-2):103-6. Epub 2006 Jun 19.

PMID:
16782270
[PubMed - indexed for MEDLINE]
19.

Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.

Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A.

Alcohol Alcohol. 2000 Mar-Apr;35(2):202-9.

PMID:
10787398
[PubMed - indexed for MEDLINE]
Free Article
20.

Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.

Mason BJ.

J Clin Psychiatry. 2001;62 Suppl 20:42-8. Review.

PMID:
11584875
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk